Literature DB >> 19124506

Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.

Nasim Mavaddat1, Alison M Dunning, Bruce A J Ponder, Douglas F Easton, Paul D Pharoah.   

Abstract

Association studies have been widely used to search for common low-penetrance susceptibility alleles to breast cancer in general. However, breast cancer is a heterogeneous disease and it has been suggested that it may be possible to identify additional susceptibility alleles by restricting analyses to particular subtypes. We used data on 710 single nucleotide polymorphisms (SNP) in 120 candidate genes from a large candidate gene association study of up to 4,470 cases and 4,560 controls to compare the results of analyses of "overall" breast cancer with subgroup analyses based on the major clinicopathologic characteristics of breast cancer (stage, grade, morphology, and hormone receptor status). No SNP was highly significant in overall effects analysis. Subgroup analysis resulted in substantial reordering of ranks of SNPs, as assessed by the magnitude of the test statistics, and some associations that were not significant for an overall effect were detected in subgroups at a nominal 5% level adjusted for multiple testing. The most significant association of CCND1 SNP rs3212879 with estrogen receptor-negative tumor types (P = 0.001) did not reach genome-wide significance levels. These results show that it may be possible to detect associations using subgroup analysis that are missed in overall effects analysis. If the associations we found can be replicated in independent studies, they may provide important insights into disease mechanisms in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124506      PMCID: PMC2655077          DOI: 10.1158/1055-9965.EPI-08-0704

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  21 in total

1.  After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

Authors:  J Cui; A C Antoniou; G S Dite; M C Southey; D J Venter; D F Easton; G G Giles; M R McCredie; J L Hopper
Journal:  Am J Hum Genet       Date:  2000-12-27       Impact factor: 11.025

2.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer.

Authors:  N Day; S Oakes; R Luben; K T Khaw; S Bingham; A Welch; N Wareham
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

3.  Polygenic susceptibility to breast cancer and implications for prevention.

Authors:  Paul D P Pharoah; Antonis Antoniou; Martin Bobrow; Ron L Zimmern; Douglas F Easton; Bruce A J Ponder
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

4.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 5.  Gene expression in inherited breast cancer.

Authors:  Ingrid A Hedenfalk; Markus Ringnér; Jeffrey M Trent; Ake Borg
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

Review 6.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

Authors: 
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

7.  A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.

Authors:  A C Antoniou; P D P Pharoah; G McMullan; N E Day; M R Stratton; J Peto; B J Ponder; D F Easton
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

8.  How many more breast cancer predisposition genes are there?

Authors:  D F Easton
Journal:  Breast Cancer Res       Date:  1999-08-23       Impact factor: 6.466

9.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

10.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer.

Authors:  A C Antoniou; P P D Pharoah; P Smith; D F Easton
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

View more
  26 in total

Review 1.  The handling of missing data in molecular epidemiology studies.

Authors:  Manisha Desai; Jessica Kubo; Denise Esserman; Mary Beth Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-12       Impact factor: 4.254

Review 2.  Genetic susceptibility to breast cancer.

Authors:  Nasim Mavaddat; Antonis C Antoniou; Douglas F Easton; Montserrat Garcia-Closas
Journal:  Mol Oncol       Date:  2010-05-21       Impact factor: 6.603

3.  Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status.

Authors:  Anika Hüsing; Federico Canzian; Lars Beckmann; Montserrat Garcia-Closas; W Ryan Diver; Michael J Thun; Christine D Berg; Robert N Hoover; Regina G Ziegler; Jonine D Figueroa; Claudine Isaacs; Anja Olsen; Vivian Viallon; Heiner Boeing; Giovanna Masala; Dimitrios Trichopoulos; Petra H M Peeters; Eiliv Lund; Eva Ardanaz; Kay-Tee Khaw; Per Lenner; Laurence N Kolonel; Daniel O Stram; Loïc Le Marchand; Catherine A McCarty; Julie E Buring; I-Min Lee; Shumin Zhang; Sara Lindström; Susan E Hankinson; Elio Riboli; David J Hunter; Brian E Henderson; Stephen J Chanock; Christopher A Haiman; Peter Kraft; Rudolf Kaaks
Journal:  J Med Genet       Date:  2012-09       Impact factor: 6.318

4.  Rat Mcs1b is concordant to the genome-wide association-identified breast cancer risk locus at human 5q11.2 and MIER3 is a candidate cancer susceptibility gene.

Authors:  Aaron D denDekker; Xin Xu; M Derek Vaughn; Aaron H Puckett; Louis L Gardner; Courtney J Lambring; Lucas Deschenes; David J Samuelson
Journal:  Cancer Res       Date:  2012-09-19       Impact factor: 12.701

5.  Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.

Authors:  Theodoros N Sergentanis; Konstantinos P Economopoulos
Journal:  Mol Biol Rep       Date:  2010-12-14       Impact factor: 2.316

6.  Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women.

Authors:  Hui Cai; Yong-Bing Xiang; Shimian Qu; Jirong Long; Qiuyin Cai; Jing Gao; Wei Zheng; Xiao Ou Shu
Journal:  Am J Epidemiol       Date:  2011-03-31       Impact factor: 4.897

7.  Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.

Authors:  Sarah J Nyante; Marilie D Gammon; Jay S Kaufman; Jeannette T Bensen; Dan Yu Lin; Jill S Barnholtz-Sloan; Yijuan Hu; Qianchuan He; Jingchun Luo; Robert C Millikan
Journal:  Cancer Causes Control       Date:  2014-11-25       Impact factor: 2.506

8.  Association of CYP8A1 (Prostacyclin I2 synthase) polymorphism rs5602 with breast cancer in Mexican woman.

Authors:  Eduardo Beltran-Sarmiento; Esaú Floriano-Sánchez; Cindy Bandala; Eleazar Lara-Padilla; Noemí Cárdenas-Rodríguez
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

9.  Association of the nibrin gene (NBN) variants with breast cancer.

Authors:  Hakan Uzunoglu; Tugcan Korak; Emel Ergul; Nihal Uren; Ali Sazci; N Zafer Utkan; Ertuğrul Kargi; Çağri Triyaki; Oktay Yirmibesoglu
Journal:  Biomed Rep       Date:  2016-01-25

10.  ESR1 polymorphisms and statin therapy: a sex-specific approach.

Authors:  L Smiderle; M Fiegenbaum; M H Hutz; C R Van Der Sand; L C Van Der Sand; M E W Ferreira; R C Pires; S Almeida
Journal:  Pharmacogenomics J       Date:  2015-08-25       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.